Clinical trial

Use of Integrated PET/CT as a First Line Staging and Re-staging Technique in Oncologic Patient.

NCT06168877

Study summary

ClinicalTrials.gov

Use of Integrated PET/CT as a First Line Staging and Re-staging Technique in Oncologic Patient.

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DIAGNOSTIC_TEST · Unmapped registry intervention Execution of 18F-FDG PET/CT and contrast-enhanced CT scan. Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2009-10-21

PhaseN/A

Conditions

Lung Cancerverified · MONDO: lung cancer

Interventions

Execution of 18F-FDG PET/CT and contrast-enhanced CT scan.DIAGNOSTIC_TEST

Sponsors & collaborators

IRCCS San Raffaelelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06168877 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.